
🇨🇳 nationals Qingzhou Wang (王庆周), aka “Bruce”, and Yiyi Chen (陈依依), aka “Chiron” — the principal executive and marketing manager of

Amarvel Biotech respectively — were sentenced to 25 and 15 years in prison on Sep 18 and Aug 22, respectively, for fentanyl precursor importation and money laundering offenses. Wang and Chen were found guilty on Feb 3, 2025, following a 2-week jury trial. Wang was also convicted of importing a methamphetamine precursor.
In addition to their respective prison terms, Wang and Chen were each sentenced to 3 years of supervised release. Wang was ordered to forfeit $67,168.25, and Chen was ordered to forfeit internet domain names for 12 websites previously seized by law enforcement.
Wuhan-based

Amarvel Biotech was a chemical manufacturer that exported vast quantities of the precursor chemicals used to manufacture fentanyl and its analogues.
Amarvel Biotech and Wang, Chen, and a sales representative, FNU LNU, aka “Er Yang,” aka “Anita” (“Yang”), shipped more than 200kg of precursor chemicals used to make fentanyl and its analogues from China to the US. They shipped the precursors to the US after being told that the chemicals would be used to produce fentanyl in New York, and then they agreed to supply multi-ton shipments of fentanyl precursors despite being told that Americans had died after consuming fentanyl made from the chemicals that the defendants had sold. In exchange, Amarvel Biotech received tens of thousands of dollars in payment in cryptocurrency.
In or about Nov 2022, Yang began negotiating the sale of fentanyl and methamphetamine precursors to a DEA confidential source (“CS-1”) posing as a fentanyl trafficker in Mexico with operations in the US. Amarvel Biotech thereafter shipped from China to New York approximately 999.7g of the fentanyl precursor 1-boc-4-AP, approximately 1,002.6g of the fentanyl precursor 1-boc-4-piperidone, and approximately 893.6g of the methamphetamine precursor methylamine.
In or about Mar 2023, Wang and Chen traveled from China to Bangkok, Thailand, to meet with an individual whom CS-1 represented was CS-1’s boss but who was in fact another DEA confidential source (“CS-2”). During the meeting, Wang and Chen discussed Amarvel Biotech’s ability to supply ton-quantities of fentanyl precursors to New York for CS-1 and CS-2’s fentanyl manufacturing operation. After CS-2 stated that CS-2 wanted a different formula for manufacturing fentanyl and that several of CS-2’s American customers had purportedly died, Wang and Chen advised they had “a lot of customers in America and Mexico” who could provide technical assistance with fentanyl production.
After the Mar 2023 meeting in Bangkok, Amarvel Biotech, Wang, Chen, and Yang agreed to sell CS-1 and CS-2 approximately 210 kilograms of fentanyl precursors, again in exchange for payment in cryptocurrency. During an Apr 10, 2023, video call with Wang and Chen, CS-2 stated that the approximately 210kg of fentanyl precursors would be used to manufacture ~50 - 55kg of fentanyl — an amount that could contain approximately 25 million deadly doses.
In or about May 2023, Amarvel Biotech, Wang, Chen, and Yang sent to the US the shipment ordered by CS-1 and CS-2. On or about May 5, 2023, the DEA retrieved the precursor shipment from a warehouse near Los Angeles, California. Lab testing confirmed the presence of a precursor chemical for a fentanyl analogue. In an encrypted messaging group chat with CS-1, CS-2, Wang, and Chen, Yang explained that “New York, the United States, has been strict in checking the precursors of the ‘final product’ some time ago, so for the sake of safety, this time it is sent to California.”
1/2
https://www.justice.gov/usao-sdny/pr/two-chinese-chemical-company-executives-sentenced-25-and-15-years-prison-respectively…